Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             45 results found
no title author magazine year volume issue page(s) type
1 Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Areall CMFs alike? A. Goldhirsch
 1998
 9 5 p. 489-493
5 p.
 article
2 A. M. Carella (ed)., Autologous stem cell transplantation: Biological andclinical results in malignancies J. Armitage
 1998
 9 5 p. 468-468
1 p.
 article
3 An overview of the Fourth International Symposium on HodgkinsDisease R. Parsa-Parsi
 1998
 9 5 p. 1-3
3 p.
 article
4 Application of interphase cytogenetics for the detection oft(11;14)(q13;q32) in mantle cell lymphomas R. Siebert
 1998
 9 5 p. 519-526
8 p.
 article
5 BEACOPP: A new regimen for advanced Hodgkins disease V. Diehl
 1998
 9 5 p. 67-71
5 p.
 article
6 Clinical phase I study with one-hour paclitaxel infusion K. Mross
 1998
 9 5 p. 569-572
4 p.
 article
7 Clinico-pathological characterization of hepatitis C virus-related B-cellnon-Hodgkins lymphomas without symptomatic cryoglobulinemia M. Luppi
 1998
 9 5 p. 495-498
4 p.
 article
8 Clonality and germinal centre B-cell derivation ofHodgkin/ReedSternberg cells in Hodgkins disease R. Küppers
 1998
 9 5 p. 17-20
4 p.
 article
9 Cost-effectiveness analysis in oncology C. C. Earle
 1998
 9 5 p. 475-482
8 p.
 article
10 Current clinical trials for the treatment of adult Hodgkins disease:Common strategies and perspectives J. Wolf
 1998
 9 5 p. 79-82
4 p.
 article
11 Enhancing the therapeutic index of concomitant chemoradiotherapy for headand neck cancer E. E. Vokes
 1998
 9 5 p. 471-473
3 p.
 article
12 EpsteinBarr virus in Hodgkins disease A. L. N. Chapman
 1998
 9 5 p. 5-16
12 p.
 article
13 Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36Health Survey in a cohort of Italian long-survival cancer patients G. Apolone
 1998
 9 5 p. 549-557
9 p.
 article
14 Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonalantibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma K. Tobinai
 1998
 9 5 p. 527-534
8 p.
 article
15 HCV and lymphoproliferative diseases C. Trépo
 1998
 9 5 p. 469-470
2 p.
 article
16 Hodgkins disease: Quality of life in future trials S. Kaasa
 1998
 9 5 p. 137-145
9 p.
 article
17 Ifosfamide given by continuous-intravenous infusion in association withvinorelbine in patients with anthracycline-resistant metastatic breast cancer:A phase III clinical trial C. Campisi
 1998
 9 5 p. 565-567
3 p.
 article
18 Improvement and plateau in survival of small-cell lung cancer since 1975:A population-based study M. L. G. Janssen-Heijnen
 1998
 9 5 p. 543-547
5 p.
 article
19 L. M. Franks, N. M. Teich (eds)., Cellular and molecular biology ofcancer. 3rd edition M. Fey
 1998
 9 5 p. 568-568
1 p.
 article
20 Long-term toxicity of the treatment of Hodgkins disease J. O. Armitage
 1998
 9 5 p. 133-136
4 p.
 article
21 Lymphocyte predominant Hodgkins disease: Pathology and clinicalimplication J. Franklin
 1998
 9 5 p. 39-44
6 p.
 article
22 Model based development of the BEACOPP regimen for advanced stageHodgkins disease M. Loeffler
 1998
 9 5 p. 73-78
6 p.
 article
23 Molecular basis of targeted chemotherapy: Novel concepts with specialreference to the treatment of Hodgkins disease H. H. Grunicke
 1998
 9 5 p. 125-128
4 p.
 article
24 New drugs in the treatment of Hodgkins disease P. Borchmann
 1998
 9 5 p. 103-108
6 p.
 article
25 Once more in St. Gallen; Cancer the main cause of death in Britain;Battle over budget: A threat for cancer research?; US cancer rates fall forthe first time; Awards, appointments; Perhaps not everyone knows that... 1998
 9 5 p. 463-468
6 p.
 article
26 Paclitaxel hypersensitivity reactions: A role for docetaxelsubstitution J. Lokich
 1998
 9 5 p. 573-573
1 p.
 article
27 Pediatric Hodgkins disease: Treatment in the late 1990s G. Schellong
 1998
 9 5 p. 115-119
5 p.
 article
28 Pneumocystis carinii pneumonia in breast cancer I. Genvresse
 1998
 9 5 p. 573-574
2 p.
 article
29 Primary refractory Hodgkins disease S. J. Horning
 1998
 9 5 p. 97-101
5 p.
 article
30 Quality of life assessment in Hodgkins disease: A new comprehensiveapproach H. Flechtner
 1998
 9 5 p. 147-154
8 p.
 article
31 Radiation therapy as a component of high-dose salvage strategies inHodgkins disease R. T. Hoppe
 1998
 9 5 p. 87-90
4 p.
 article
32 Radiotherapy in early stage Hodgkins disease: Principles and results ofrecent clinical trials E. M. Noordijk
 1998
 9 5 p. 63-65
3 p.
 article
33 Randomized controlled trials in cancer: Improving the quality of theirreports will also facilitate better conduct D. Moher
 1998
 9 5 p. 483-487
5 p.
 article
34 Rare syndromes in Hodgkins disease F. Cavalli
 1998
 9 5 p. 109-113
5 p.
 article
35 R. Dunlop., Cancer: Palliative care (focus on cancer) H. Neuenschwander
 1998
 9 5 p. 474-474
1 p.
 article
36 Selective cytoprotection with amifostine in concurrent radiochemotherapyfor head and neck cancer J. Büntzel
 1998
 9 5 p. 505-509
5 p.
 article
37 The case for and against high-dose therapy with stem cell rescue forearly poor prognosis Hodgkins disease in first remission A. H. Goldstone
 1998
 9 5 p. 83-85
3 p.
 article
38 The impact of adding low-dose leucovorin to monthly 5-fluorouracil inadvanced colorectal carcinoma: Results of a phase III trial M. M. Borner
 1998
 9 5 p. 535-541
7 p.
 article
39 The many faces of Hodgkins disease around the world: What have welearned from its pathology? N. L. Harris
 1998
 9 5 p. 45-56
12 p.
 article
40 The role of radiotherapy for early stage Hodgkins disease: Limitationsand perspectives J.-M. Cosset
 1998
 9 5 p. 57-62
6 p.
 article
41 Treatment of grey zone lymphomas R. I. Fisher
 1998
 9 5 p. 121-123
3 p.
 article
42 Treatment of relapsed Hodgkins disease: Strategies and prognosticfactors G. P. Canellos
 1998
 9 5 p. 91-96
6 p.
 article
43 Treatment of relapsed Hodgkins disease using EBV-specific cytotoxic Tcells C. M. Rooney
 1998
 9 5 p. 129-132
4 p.
 article
44 Workshop report on Hodgkins lymphoma and related diseases (grey zonelymphoma) T. Rüdiger
 1998
 9 5 p. 31-38
8 p.
 article
45 World Health Organization Classification of lymphomas: A work inprogress E. S. Jaffe
 1998
 9 5 p. 25-30
6 p.
 article
                             45 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands